Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON SUN PHARMA BIOCON /
SUN PHARMA
 
P/E (TTM) x 34.8 55.4 62.7% View Chart
P/BV x 4.3 4.7 91.6% View Chart
Dividend Yield % 0.2 1.1 15.9%  

Financials

 BIOCON    SUN PHARMA
EQUITY SHARE DATA
    BIOCON
Mar-22
SUN PHARMA
Mar-22
BIOCON /
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs424931 45.6%   
Low Rs315593 53.1%   
Sales per share (Unadj.) Rs68.2161.1 42.3%  
Earnings per share (Unadj.) Rs8.214.2 57.4%  
Cash flow per share (Unadj.) Rs14.923.1 64.6%  
Dividends per share (Unadj.) Rs0.5010.00 5.0%  
Avg Dividend yield %0.11.3 10.3%  
Book value per share (Unadj.) Rs68.5200.1 34.3%  
Shares outstanding (eoy) m1,200.602,399.34 50.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.44.7 114.6%   
Avg P/E ratio x45.353.7 84.5%  
P/CF ratio (eoy) x24.732.9 75.1%  
Price / Book Value ratio x5.43.8 141.6%  
Dividend payout %6.170.4 8.7%   
Avg Mkt Cap Rs m443,6221,827,693 24.3%   
No. of employees `000NANA-   
Total wages/salary Rs m18,80173,008 25.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m81,840386,545 21.2%  
Other income Rs m6,89114,374 47.9%   
Total revenues Rs m88,731400,919 22.1%   
Gross profit Rs m13,82753,150 26.0%  
Depreciation Rs m8,14221,437 38.0%   
Interest Rs m6761,274 53.1%   
Profit before tax Rs m11,90044,813 26.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,11510,755 19.7%   
Profit after tax Rs m9,78534,058 28.7%  
Gross profit margin %16.913.7 122.9%  
Effective tax rate %17.824.0 74.1%   
Net profit margin %12.08.8 135.7%  
BALANCE SHEET DATA
Current assets Rs m83,823350,150 23.9%   
Current liabilities Rs m38,280172,006 22.3%   
Net working cap to sales %55.646.1 120.7%  
Current ratio x2.22.0 107.6%  
Inventory Days Days101149 67.6%  
Debtors Days Days92100 91.8%  
Net fixed assets Rs m117,184318,882 36.7%   
Share capital Rs m6,0032,399 250.2%   
"Free" reserves Rs m76,281477,713 16.0%   
Net worth Rs m82,284480,112 17.1%   
Long term debt Rs m39,9852,299 1,739.1%   
Total assets Rs m201,007669,032 30.0%  
Interest coverage x18.636.2 51.4%   
Debt to equity ratio x0.50 10,147.2%  
Sales to assets ratio x0.40.6 70.5%   
Return on assets %5.25.3 98.5%  
Return on equity %11.97.1 167.6%  
Return on capital %10.39.6 107.7%  
Exports to sales %00-   
Imports to sales %7.80-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m6,360NA-   
Fx inflow Rs m8,885106,331 8.4%   
Fx outflow Rs m6,36071,874 8.8%   
Net fx Rs m2,52534,456 7.3%   
CASH FLOW
From Operations Rs m11,76689,845 13.1%  
From Investments Rs m-16,991-57,247 29.7%  
From Financial Activity Rs m2,421-51,935 -4.7%  
Net Cashflow Rs m-2,433-17,648 13.8%  

Share Holding

Indian Promoters % 39.7 54.5 72.9%  
Foreign collaborators % 20.9 0.0 -  
Indian inst/Mut Fund % 24.0 34.6 69.4%  
FIIs % 16.3 15.0 109.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 45.5 86.5%  
Shareholders   341,016 647,167 52.7%  
Pledged promoter(s) holding % 0.0 4.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   CIPLA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    PIRAMAL ENTERPRISES    


More on Biocon vs Sun Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Biocon vs Sun Pharma Share Price Performance

Period Biocon Sun Pharma S&P BSE HEALTHCARE
1-Day 1.58% 0.05% 0.71%
1-Month 1.30% 6.78% 3.96%
1-Year -18.72% 13.62% -11.08%
3-Year CAGR 8.65% 34.79% 24.52%
5-Year CAGR -2.68% 12.79% 11.41%

* Compound Annual Growth Rate

Here are more details on the Biocon share price and the Sun Pharma share price.

Moving on to shareholding structures...

The promoters of Biocon hold a 60.6% stake in the company. In case of Sun Pharma the stake stands at 54.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Biocon and the shareholding pattern of Sun Pharma.

Finally, a word on dividends...

In the most recent financial year, Biocon paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 6.1%.

Sun Pharma paid Rs 10.0, and its dividend payout ratio stood at 70.4%.

You may visit here to review the dividend history of Biocon, and the dividend history of Sun Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Rallies 1,200 Points, Nifty Above 17,200; IndusInd Bank, Bajaj Finance & Adani Ports Surge 4%(10:30 am)

Asian share markets opened higher today after Wall Street shares rebounded, with the rise coming despite a North Korean missile test shortly before the opening bell.